Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4+ cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status

Blood

Volumn 99, Issue 2, 2002, Pages 590-599

  Villinger, Francois ^a,b,c,d,e   Brice, Gary T ^a,b,c,d   Mayne, Ann E ^a,b,c,d   Bostik, Pavel ^a,b,c,d   Mori, Kazuyasu ^a,b,c,d   June, Carl H ^a,b,c,d   Ansari, Aftab A ^a,b,c,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMPARTMENTALIZATION; CELL FUNCTION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; IMMUNE RESPONSE; MACACA; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; VIRUS LOAD;

EID: 0037079727     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.2.590     Document Type: Article

References (48)

1. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. Immune reconstitution and immunotherapy in HIV infection
4. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
5. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS
6. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: A predominant gag-specific response is associated with nonprogressive infection
7. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
8. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
9. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
10. Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections
11. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/IV chimeric virus infections of macaque monkeys
12. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
13. A preliminary study to determine the effect of an infusion of cryopreserved autologous lymphocytes on immunocompetence and viral load in HIV-infected patients
14. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients
15. Deficient cellular immunity-finding and fixing the defects
16. Human immunodeficiency virus Tat induces functional unresponsiveness in T cells
17. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71)
18. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection
19. Impaired CD45-associated tyrosine phosphatase activity during HIV-1 infection: Implications for CD3 and CD4 receptor signalling
20. Defective signal transduction-a common pathway for cellular dysfunction in HIV infection?
21. Neutralizing and infection-enhancing anti-body responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys
22. Evidence for selective loss of low determinant density requiring T cells following acute viremia phase in normal progressor but not long-term non progressor infected rhesus macaques
23. In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS
24. Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human pri-mates
25. Regulation of immune activation/retroviral replication by CD8+ T cells
26. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine
27. Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques
28. Hematopoietic response to lineage-non-specific (rrlL-3) and lineage-specific (rhG-CSF, rhEpo, rhTpo) cytokine administration in SIV-infected rhesus macaques is related to stage of infection
29. Early loss of antigen induced IFNgamma with gradual increase in IL-6 in macaques infected with SIV-mac251 as they progress towards AIDS
30. Control mechanisms of virus replication in naturally SIVsmm infected mangabeys and experimentally infected macaques
31. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults
32. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
33. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression
34. Failure of allogeneic bone marrow transplantation to benefit HIV infection
35. Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS
36. Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression
37. Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant
38. Cellular immunotherapy of advanced human immunodeficiency virus type 1 infection using autologous lymph node lymphocytes: Effects on chemokine production
39. T-cell therapy of cyto-megalovirus and human immunodeficiency virus infection
40. Large scale production of CD4+ T cells from HIV-infected donors following CD3/CD28 stimulation
41. Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects
42. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death
43. Non-human primate models for AIDS vaccines
44. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation
45. A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses
46. Development of an animal model for autotransfusion therapy: In vitro characterization and analysis of anti-CD3/CD28 expanded cells
47. Immune control of HIV-1 after early treatment of acute infection
48. Limiting dilution assays. Experimental design and statistical analysis